secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001213900-24-092879
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne expands Zimmer Biomet distribution deal for OneRF Ablation System; $3M upfront
--------------------------------------------------------------------------------

- Zimmer Biomet gets exclusive US and certain OUS distribution rights for OneRF Ablation System.
- NeuroOne receives $3M upfront within 10 business days plus up to $1M milestone payment.
- OneRF is only FDA-cleared RF ablation system for both diagnostic and therapeutic brain use.
- Agreement effective Oct 25, 2024, term to Sep 30, 2034 unless earlier terminated.
- NeuroOne expects meaningful revenue and improved profitability from the agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024092879/0001213900-24-092879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024092879/ea0219340-8k_neuro.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-092879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer